fenoldopam has been researched along with Psoriasis in 2 studies
Fenoldopam: A dopamine D1 receptor agonist that is used as an antihypertensive agent. It lowers blood pressure through arteriolar vasodilation.
Psoriasis: A common genetically determined, chronic, inflammatory skin disease characterized by rounded erythematous, dry, scaling patches. The lesions have a predilection for nails, scalp, genitalia, extensor surfaces, and the lumbosacral region. Accelerated epidermopoiesis is considered to be the fundamental pathologic feature in psoriasis.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Keren, A | 1 |
| Gilhar, A | 1 |
| Ullmann, Y | 1 |
| Zlotkin-Frušić, M | 1 |
| Soroka, Y | 1 |
| Domb, AJ | 2 |
| Levite, M | 1 |
| Doppalapudi, S | 1 |
| Jain, A | 1 |
| Khan, W | 1 |
2 other studies available for fenoldopam and Psoriasis
| Article | Year |
|---|---|
Instantaneous depolarization of T cells via dopamine receptors, and inhibition of activated T cells of Psoriasis patients and inflamed human skin, by D1-like receptor agonist: Fenoldopam.
Topics: Adult; Antigens, CD; Antigens, Differentiation, T-Lymphocyte; CD28 Antigens; Cytokines; Female; Feno | 2019 |
Fenoldopam mesylate for treating psoriasis: A new indication for an old drug.
Topics: Acrylic Resins; Administration, Cutaneous; Animals; Chemistry, Pharmaceutical; Disease Models, Anima | 2020 |